New Zealand markets open in 3 hours 2 minutes

Adial Pharmaceuticals, Inc. (ADIL)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.5000-0.1500 (-9.09%)
At close: 04:00PM EDT
1.5200 +0.02 (+1.33%)
After hours: 07:26PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 6.08M
Enterprise value 3.96M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.49
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.31

Trading information

Stock price history

Beta (5Y monthly) 1.41
52-week change 3-81.25%
S&P500 52-week change 326.27%
52-week high 314.0000
52-week low 30.7700
50-day moving average 31.8084
200-day moving average 32.3281

Share statistics

Avg vol (3-month) 36.55M
Avg vol (10-day) 3166.85k
Shares outstanding 54.05M
Implied shares outstanding 64.05M
Float 83.94M
% held by insiders 14.04%
% held by institutions 16.13%
Shares short (30 Apr 2024) 4167.07k
Short ratio (30 Apr 2024) 40.02
Short % of float (30 Apr 2024) 44.26%
Short % of shares outstanding (30 Apr 2024) 44.12%
Shares short (prior month 28 Mar 2024) 48.65k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:25
Last split date 307 Aug 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-82.24%
Return on equity (ttm)-190.27%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -6.89M
Net income avi to common (ttm)-7M
Diluted EPS (ttm)-4.9100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.83M
Total cash per share (mrq)0.7
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)4.90
Book value per share (mrq)2.45

Cash flow statement

Operating cash flow (ttm)-6.81M
Levered free cash flow (ttm)-3.21M